Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Nanovibronix Inc NAOV

Healthcare Medical Devices
NanoVibronix, Inc. is a medical device company. The Company develops medical devices utilizing its patented low intensity surface acoustic wave technology. Its products include UroShield and PainShield. UroShield is an ultrasound-based product that is designed to prevent bacterial colonization and biofilm in urinary catheters, increase antibiotic efficacy and decrease pain and discomfort... see more

Recent & Breaking News (NDAQ:NAOV)

NanoVibronix Selects Key Distributor to Exclusively Distribute PainShield for Veterans Administration Facilities

Business Wire January 5, 2022

NanoVibronix Adjourns Special Meeting of Stockholders

GlobeNewswire December 21, 2021

NanoVibronix Announces Agreement With Medina Healthcare Limited for Distribution of UroShield® and PainShield® in European Market Expansion

Business Wire December 21, 2021

NANOVIBRONIX TO SHOWCASE PAINSHIELD PRODUCTS AT 75TH ANNUAL WORKERS' COMPENSATION EDUCATIONAL CONFERENCE DECEMBER 12-15

GlobeNewswire December 8, 2021

NanoVibronix Announces Encouraging Interim Results in Real World Patient Study of UroShield

GlobeNewswire December 7, 2021

NanoVibronix Announces Early Success in the Marketing of Painshield to Veteran's Administration Healthcare Providers

GlobeNewswire December 2, 2021

NanoVibronix Reports Third Quarter 2021 Financial Results

Business Wire November 16, 2021

NanoVibronix CEO Brian Murphy Provides Business Update in Letter to Shareholders

GlobeNewswire October 28, 2021

NANOVIBRONIX ANNOUNCES POSITIVE RESULTS FROM INDEPENENT, DOUBLE-BLIND TRIAL OF PAINSHIELD

GlobeNewswire October 11, 2021

NANOVIBRONIX ENTERS WORKER'S COMPENSATION MARKET THROUGH AGREEMENT WITH ORCHID MEDICAL

GlobeNewswire September 29, 2021

NANOVIBRONIX EXTENDS LINE-UP OF PAIN MANAGEMENT PRODUCTS

GlobeNewswire September 14, 2021

NanoVibronix Announces Results of Annual Meeting of Stockholders Held Today

Business Wire August 17, 2021

NANOVIBRONIX ANNOUNCES PLAN TO EXPAND PRODUCT PORTFOLIO WITH INTRODUCTION OF PAINSHIELD RELIEF FOR OVER-THE-COUNTER (OTC) USE AND PLANS FOR FUTURE PRODUCT LAUNCH

GlobeNewswire August 16, 2021

NANOVIBRONIX RECEIVES REGISTRATION APPROVAL FOR PAINSHIELD FROM TGA AUSTRALIA

GlobeNewswire August 11, 2021

NanoVibronix Applies for CMS Reimbursement Code for UroShield® and PainShield Plus®

Business Wire August 5, 2021

NanoVibronix Ships First Order of PainShield Plus

Business Wire July 26, 2021

NanoVibronix Announces Publication of Compelling Study Results for UroShield in The Journal of Medical & Surgical Urology

GlobeNewswire July 22, 2021

NanoVibronix Provides Business Update

GlobeNewswire June 3, 2021

NanoVibronix Adjourns Special Meeting of Stockholders

GlobeNewswire April 27, 2021

NanoVibronix Announces Expanded CMS Reimbursement Approval for PainShield

GlobeNewswire April 26, 2021